EX-23.1 3 g21769exv23w1.htm EX-23.1

exv23w1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors
Cumberland Pharmaceuticals Inc.:

We consent to the use of our report incorporated by reference herein.

/S/ KPMG LLP  

KPMG LLP 

Nashville, Tennessee
January 14, 2010